Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

PATCH 2&3:Prevention & Treatment of COVID-19 (Severe Acute Respiratory Syndrome Coronavirus 2) With Hydroxychloroquine

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04353037
Recruitment Status : Terminated (As enrollment began external studies called into question the safety and efficacy of hydroxychloroquine as a treatment which resulted in controversy. The timing of the controversy significantly impacted our ability to enroll and retain participants.)
First Posted : April 20, 2020
Last Update Posted : March 12, 2021
Sponsor:
Collaborators:
ProHealth Care Associates
University of Pennsylvania Perelman School of Medicine
Information provided by (Responsible Party):
Dr. Deneen Vojta, UnitedHealth Group

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : July 11, 2020
Actual Study Completion Date : July 11, 2020
Publications: